ALXO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Alx Oncology Holdings Inc (ALXO).


$88.08M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

ALXO Market Cap. (MRY)


ALXO Shares Outstanding (MRY)


ALXO Assets (MRY)


Total Assets

$147.78M

Total Liabilities

$34.16M

Total Investments

$113.71M

ALXO Income (MRY)


Revenue

$0

Net Income

-$134.85M

Operating Expense

$142.47M

ALXO Cash Flow (MRY)


CF Operations

-$121.91M

CF Investing

$86.26M

CF Financing

$30.82M

ALXO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ALXO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$147,775,000 (-39.08%)

$242,553,000 (-20.86%)

$306,489,000 (-19.38%)

$380,183,000 (-12.81%)

Assets Current

$134,352,000 (-28.79%)

$188,659,000 (-30.38%)

$270,969,000 (-26.17%)

$367,019,000 (-15.82%)

Assets Non-Current

$13,423,000 (-75.09%)

$53,894,000 (51.73%)

$35,520,000 (169.83%)

$13,164,000 (21132.26%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$113,618,000 (-40.11%)

$189,712,000 (-27.99%)

$263,464,000 (-27.43%)

$363,049,000 (-15.54%)

Property Plant & Equipment Net

$2,905,000 (-19.06%)

$3,589,000 (-7.71%)

$3,889,000 (333.56%)

$897,000 (1625.00%)

Cash & Equivalents

$17,567,000 (-21.60%)

$22,406,000 (-54.11%)

$48,822,000 (-86.58%)

$363,667,000 (-16.25%)

Accumulated Other Comprehensive Income

$275,000 (7.42%)

$256,000 (130.30%)

-$845,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$113,714,000 (-41.91%)

$195,741,000 (-16.38%)

$234,084,000 (0%)

$0 (0%)

Investments Current

$110,190,000 (-31.27%)

$160,330,000 (-26.25%)

$217,385,000 (0%)

$0 (0%)

Investments Non-Current

$3,524,000 (-90.05%)

$35,411,000 (112.05%)

$16,699,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,646,000 (-49.14%)

$9,134,000 (-6.06%)

$9,723,000 (80.26%)

$5,394,000 (6997.37%)

Accumulated Retained Earnings (Deficit)

-$621,122,000 (-27.73%)

-$486,272,000 (-49.41%)

-$325,467,000 (-61.13%)

-$201,985,000 (-70.42%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$9,904,000 (2.75%)

$9,639,000 (2.66%)

$9,389,000 (0%)

$0 (0%)

Debt Current

$435,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$9,469,000 (-1.76%)

$9,639,000 (2.66%)

$9,389,000 (0%)

$0 (0%)

Total Liabilities

$34,157,000 (-35.36%)

$52,841,000 (22.81%)

$43,025,000 (151.11%)

$17,134,000 (175.95%)

Liabilities Current

$18,500,000 (-48.61%)

$36,001,000 (27.10%)

$28,325,000 (85.19%)

$15,295,000 (146.53%)

Liabilities Non-Current

$15,657,000 (-7.02%)

$16,840,000 (14.56%)

$14,700,000 (699.35%)

$1,839,000 (36680.00%)

ALXO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$26,094,000 (-8.39%)

$28,483,000 (-1.90%)

$29,036,000 (24.17%)

$23,385,000 (57.91%)

Research & Development Expense

$116,373,000 (-17.93%)

$141,795,000 (44.10%)

$98,400,000 (63.54%)

$60,170,000 (107.76%)

Operating Expenses

$142,467,000 (-16.33%)

$170,278,000 (33.62%)

$127,436,000 (52.52%)

$83,555,000 (90.90%)

Interest Expense

$1,729,000 (10.48%)

$1,565,000 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$64,000 (404.76%)

-$21,000 (-108.71%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$134,850,000 (16.14%)

-$160,805,000 (-30.23%)

-$123,482,000 (-47.95%)

-$83,463,000 (-82.47%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$134,850,000 (16.14%)

-$160,805,000 (-30.23%)

-$123,482,000 (-47.95%)

-$83,463,000 (-82.47%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$134,850,000 (16.14%)

-$160,805,000 (-30.23%)

-$123,482,000 (-47.95%)

-$83,463,000 (-63.84%)

Weighted Average Shares

$52,174,904 (21.37%)

$42,987,767 (5.62%)

$40,699,612 (0.97%)

$40,308,050 (118.05%)

Weighted Average Shares Diluted

$52,174,904 (21.37%)

$42,987,767 (5.62%)

$40,699,612 (0.97%)

$40,308,050 (118.05%)

Earning Before Interest & Taxes (EBIT)

-$133,121,000 (16.40%)

-$159,240,000 (-29.02%)

-$123,418,000 (-47.83%)

-$83,484,000 (-83.49%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$142,467,000 (16.33%)

-$170,278,000 (-33.62%)

-$127,436,000 (-52.52%)

-$83,555,000 (-91.36%)

ALXO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$86,256,000 (93.15%)

$44,657,000 (118.97%)

-$235,416,000 (-4681.96%)

-$4,923,000 (-907.05%)

Net Cash Flow from Financing

$30,817,000 (-48.02%)

$59,291,000 (501.33%)

$9,860,000 (298.87%)

$2,472,000 (-99.47%)

Net Cash Flow from Operations

-$121,912,000 (6.48%)

-$130,364,000 (-46.11%)

-$89,223,000 (-31.02%)

-$68,101,000 (-77.86%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,839,000 (81.68%)

-$26,416,000 (91.61%)

-$314,779,000 (-346.17%)

-$70,552,000 (-116.59%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$86,703,000 (88.77%)

$45,931,000 (119.63%)

-$233,989,000 (0%)

$0 (0%)

Capital Expenditure

-$447,000 (64.91%)

-$1,274,000 (10.72%)

-$1,427,000 (-114.26%)

-$666,000 (-2048.39%)

Issuance (Repayment) of Debt Securities

-$827,000 (-113.14%)

-$388,000 (-104.33%)

$8,957,000 (3287.54%)

-$281,000 (95.68%)

Issuance (Purchase) of Equity Shares

$31,644,000 (-46.98%)

$59,679,000 (6508.97%)

$903,000 (-67.20%)

$2,753,000 (-99.25%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$27,093,000 (3.12%)

$26,273,000 (10.21%)

$23,839,000 (71.33%)

$13,914,000 (155.96%)

Depreciation Amortization & Accretion

$872,000 (4.31%)

$836,000 (144.44%)

$342,000 (570.59%)

$51,000 (-74.75%)

ALXO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-94.00% (-18.54%)

-79.30% (-94.36%)

-40.80% (-92.45%)

-21.20% (45.78%)

Return on Average Assets (ROAA)

-70.90% (-8.74%)

-65.20% (-76.22%)

-37.00% (-81.37%)

-20.40% (8.93%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-86.60% (-4.84%)

-82.60% (-55.26%)

-53.20% (-101.66%)

3206.00% (187.97%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.65 (83.75%)

-3.98 (-7.04%)

-3.72 (64.18%)

-10.38 (66.76%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.78 (-80.18%)

3.91 (124.33%)

1.74 (-27.28%)

2.4 (-67.79%)

Debt to Equity Ratio (D/E)

0.3 (7.89%)

0.28 (71.17%)

0.16 (246.81%)

0.05 (235.71%)

Earnings Per Share (EPS)

-2.58 (31.02%)

-3.74 (-23.43%)

-3.03 (-46.38%)

-2.07 (25.00%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.35 (23.42%)

-3.06 (-37.49%)

-2.23 (-30.54%)

-1.71 (17.70%)

Book Value Per Share (BVPS)

2.18 (-50.65%)

4.41 (-31.82%)

6.47 (-28.13%)

9.01 (-61.27%)

Tangible Assets Book Value Per Share (TABVPS)

2.83 (-49.81%)

5.64 (-25.08%)

7.53 (-20.15%)

9.43 (-60.02%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (80.00%)

-5 (-66.67%)

-3 (50.00%)

-6 (90.77%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.62 (86.60%)

-4.62 (-38.61%)

-3.33 (42.68%)

-5.82 (91.06%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

7.26 (38.59%)

5.24 (-45.22%)

9.57 (-60.14%)

24 (-65.85%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$122,359,000 (7.05%)

-$131,638,000 (-45.22%)

-$90,650,000 (-31.82%)

-$68,767,000 (-79.45%)

Enterprise Value (EV)

$81,813,984 (-88.82%)

$731,793,111 (78.37%)

$410,259,944 (-15.44%)

$485,186,072 (-83.52%)

Earnings Before Tax (EBT)

-$134,850,000 (16.14%)

-$160,805,000 (-30.29%)

-$123,418,000 (-47.83%)

-$83,484,000 (-83.49%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$132,249,000 (16.51%)

-$158,404,000 (-28.70%)

-$123,076,000 (-47.51%)

-$83,433,000 (-84.19%)

Invested Capital

$121,612,000 (-37.24%)

$193,785,000 (-18.83%)

$238,731,000 (19452.09%)

$1,221,000 (127.95%)

Working Capital

$115,852,000 (-24.11%)

$152,658,000 (-37.09%)

$242,644,000 (-31.01%)

$351,724,000 (-18.16%)

Tangible Asset Value

$147,775,000 (-39.08%)

$242,553,000 (-20.86%)

$306,489,000 (-19.38%)

$380,183,000 (-12.81%)

Market Capitalization

$88,080,984 (-88.13%)

$741,802,111 (61.50%)

$459,313,944 (-47.23%)

$870,335,072 (-72.79%)

Average Equity

$143,484,250 (-29.28%)

$202,886,000 (-32.95%)

$302,585,500 (-22.99%)

$392,929,750 (201.36%)

Average Assets

$190,189,500 (-22.90%)

$246,682,500 (-26.03%)

$333,468,000 (-18.37%)

$408,527,500 (79.57%)

Invested Capital Average

$153,802,000 (-20.21%)

$192,769,250 (-16.83%)

$231,773,250 (9000.66%)

-$2,604,000 (-308.57%)

Shares

52,743,104 (5.87%)

49,818,812 (22.24%)

40,755,452 (0.63%)

40,499,538 (9.14%)